Who
Reza Zadno
Director
Company insider
Files Form 4 as: Director, Mobia Medical; President, CEO, PROCEPT BioRobotics; President and CEO, Avedro; Director, Invuity; Director, Carbylan Therapeutics.
In numbers
- Trades disclosed
- 78
- Buys
- 0
- Sells
- 11
- Bought
- $0
- Sold
- $38.5M
- Companies
- 5
- Companies where not an officer
- 3
- First trade
- 24 Apr 2015
- Last trade
- 14 Jul 2026
- Last filed
- 16 Jul 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 14 Jul 2026filed 16 Jul 2026 | MOBI Mobia Medicaloption or derivative · Medical Devices | SEC FORM 4 Code A | —19,150 at $0.00 | filing |
| 14 Jul 2026filed 16 Jul 2026 | MOBI Mobia Medicaloption or derivative · Medical Devices | SEC FORM 4 Code A | —16,260 at $0.00 | filing |
| 14 Jul 2026filed 16 Jul 2026 | MOBI Mobia Medicaloption or derivative · Medical Devices | SEC FORM 4 Code A | —19,150 at $0.00 | filing |
| 14 Jul 2026filed 16 Jul 2026 | MOBI Mobia Medicaloption or derivative · Medical Devices | SEC FORM 4 Code A | —16,260 at $0.00 | filing |
| 9 May 2025filed 13 May 2025 | PRCT PROCEPT BioRoboticsoption or derivative · Medical Devices | SEC FORM 4 Code M | —13,759 at $0.00 | filing |
| 9 May 2025filed 13 May 2025 | PRCT PROCEPT BioRoboticsMedical Devices | SEC FORM 4 Code M | $100K13,759 at $7.27 | filing |
| 18 Mar 2025filed 19 Mar 2025 | PRCT PROCEPT BioRoboticsMedical Devices | SEC FORM 4 Sold | $312K5,475 at $57.06 | filing |
| 6 Mar 2025filed 10 Mar 2025 | PRCT PROCEPT BioRoboticsMedical Devices | SEC FORM 4 Sold | $976K15,916 at $61.31 | filing |
| 3 Mar 2025filed 5 Mar 2025 | PRCT PROCEPT BioRoboticsoption or derivative · Medical Devices | SEC FORM 4 Code A | —36,831 at $0.00 | filing |
| 3 Mar 2025filed 5 Mar 2025 | PRCT PROCEPT BioRoboticsMedical Devices | SEC FORM 4 Code A | —41,699 at $0.00 | filing |
| 4 Dec 2024filed 6 Dec 2024 | PRCT PROCEPT BioRoboticsMedical Devices | SEC FORM 4 Sold | $510K5,300 at $96.15 | filing |
| 4 Dec 2024filed 6 Dec 2024 | PRCT PROCEPT BioRoboticsMedical Devices | SEC FORM 4 Sold | $1.3M13,762 at $97.01 | filing |
| 4 Dec 2024filed 6 Dec 2024 | PRCT PROCEPT BioRoboticsMedical Devices | SEC FORM 4 Sold | $503K5,126 at $98.09 | filing |
| 4 Dec 2024filed 6 Dec 2024 | PRCT PROCEPT BioRoboticsMedical Devices | SEC FORM 4 Sold | $221K2,235 at $99.04 | filing |
| 27 Nov 2024filed 2 Dec 2024 | PRCT PROCEPT BioRoboticsMedical Devices | SEC FORM 4 Sold | $1.8M18,144 at $97.25 | filing |
| 27 Nov 2024filed 2 Dec 2024 | PRCT PROCEPT BioRoboticsMedical Devices | SEC FORM 4 Sold | $165K1,684 at $98.00 | filing |
| 27 Nov 2024filed 2 Dec 2024 | PRCT PROCEPT BioRoboticsMedical Devices | SEC FORM 4 Sold | $515K5,189 at $99.24 | filing |
| 27 Nov 2024filed 2 Dec 2024 | PRCT PROCEPT BioRoboticsMedical Devices | SEC FORM 4 Sold | $140K1,403 at $99.96 | filing |
| 20 Nov 2024filed 22 Nov 2024 | PRCT PROCEPT BioRoboticsMedical Devices | SEC FORM 4 Sold | $931K10,111 at $92.12 | filing |
| 20 Nov 2024filed 22 Nov 2024 | PRCT PROCEPT BioRoboticsMedical Devices | SEC FORM 4 Sold | $1.5M15,809 at $92.82 | filing |
News
No headline names them, or the companies they trade most, lately.